HMB

The Kinetix Group and Converging Health Release Early Findings on Women's Health from Collaborative Partnership

Retrieved on: 
Tuesday, June 7, 2022
Woman, Partnership, HMB, Awareness, Health, Organization, View, International, TKG, Anemia, Multimedia, Birth control, Management, Medicine, MD

NEW YORK, June 7, 2022 /PRNewswire/ -- The Kinetix Group (TKG) and Converging Health released some early insights from their collaborative work.

Key Points: 
  • NEW YORK, June 7, 2022 /PRNewswire/ -- The Kinetix Group (TKG) and Converging Health released some early insights from their collaborative work.
  • Earlier this year, the two companies announced a collaborative partnership to apply data and expert insights to unmet health needs as well as determine their corresponding cost implications.
  • For more information on the findings, please contact Mindy Olivarez, vice president of innovation at The Kinetix Group, at [email protected] .
  • Converging Health is a healthcare data analytics company that delivers actionable insights to enable informed decisions that improve outcomes clinically and operationally.

ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

Retrieved on: 
Wednesday, May 25, 2022
International Society, Catholic higher education, HMB, Gynecological Endocrinology, EDELWEISS, Uterine fibroid, Catholic University of Leuven (1834–1968), Doctor of Philosophy, World Congress, PRIMROSE, NASDAQ, LGX, Constipation, Gonadotropin-releasing hormone, Treatment, DYS, Uterus, MBL, Congress, Yale School of Medicine, Safety, Dysmenorrhea, ABT, Pharmaceutical industry, Birth control, Medical imaging, Endometriosis, Woman, MD

GENEVA, Switzerland May 25, 2022 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced the presentation of clinical data on linzagolix, an oral GnRH antagonist.

Key Points: 
  • GENEVA, Switzerland May 25, 2022 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced the presentation of clinical data on linzagolix, an oral GnRH antagonist.
  • The encouraging data presented at these important medical congresses highlight the differentiated therapeutic potential of linzagolix to better address the individual needs of women with uterine fibroids and endometriosis, said Dr. Brandi Howard, Chief Clinical Officer of ObsEva.
  • These data demonstrate that linzagolix with or without add-back therapy (ABT) significantly reduced heavy menstrual bleeding due to uterine fibroids.
  • Linzagolix is an investigational novel, once daily, oral GnRH receptor antagonist with a potentially best-in-class profile1,2,3.

Nirvana Water Sciences Hits an Ace with Greg Norman

Retrieved on: 
Tuesday, March 15, 2022
HMB, Authentic Brands Group, Digital media, Arrow, Facebook, Health, Partnership, Barneys New York, Nautica, Brooks Brothers, Muscle, Chief executive officer, ABG, Water, Great white shark, Golf, Volcom, Drexel, Frederick's of Hollywood, Nirvana, Company, Research, CEO, Izod, Lucky Brand Jeans, LinkedIn, Marketing, Video game, Dietary supplement, Fashion, Reebok, Instagram, Spyder

FORESTPORT, N.Y., March 15, 2022 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana") has elevated its game through a new partnership with Greg Norman that aims to continue driving Nirvana's mission of living longer by living strongerTM.

Key Points: 
  • FORESTPORT, N.Y., March 15, 2022 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana") has elevated its game through a new partnership with Greg Norman that aims to continue driving Nirvana's mission of living longer by living strongerTM.
  • - Greg Norman
    Arguably the most successful athlete-turned-businessman in the world, Norman is known as much for his business savvy as his dominance on the golf course.
  • Through this partnership with Nirvana, Norman serves as a spokesperson and strategic advisor to help Nirvana grow its distribution through both golf-specific and traditional retail channels.
  • "Nirvana Water Sciences has developed a quality, science-backed infused spring water product line that transcends hydration, and delivers on its promise of muscle wellness," commented Norman.

Nirvana Water Sciences Introduces A Powerful New Functional Water

Retrieved on: 
Thursday, March 3, 2022
FACS, Athlete, Research, Science, Yoga, Immunity, Coronavirus Scientific Advisory Board (Turkey), Muscle, HMB, MD, D3, Cholecalciferol, Water, Dietary supplement, Q3, Nirvana

NEW YORK, March 3, 2022 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana") will introduce Nirvana HMB + Vitamin D3 spring water at Expo West in Anaheim, California March 8-12.

Key Points: 
  • NEW YORK, March 3, 2022 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana") will introduce Nirvana HMB + Vitamin D3 spring water at Expo West in Anaheim, California March 8-12.
  • The newest member in a family of innovative, functional beverages infused with science-backed benefits, Nirvana HMB + Vitamin D3 packs a powerful punch mixing muscle recovery with immunity.
  • About Nirvana Water Sciences Corp.
    Nirvana Water Sciences Corp. has harnessed the muscle wellness properties of HMB and infused it into spring water, creating an innovative and truly functional bottled water.
  • Living longer by living strongerTMis the science-backed foundation on which Nirvana Water Sciences is building a leading functional water brand.

ObsEva Announces Symposium and Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at SEUD Congress 2021

Retrieved on: 
Thursday, December 2, 2021
Private Securities Litigation Reform Act, Security (finance), Long-Term Capital Management, SIX Swiss Exchange, U.S. Securities and Exchange Commission, Review, Coronavirus, Risk, Birth certificate, Health, HMB, Report, SEC, Gonadotropin-releasing hormone, Investor, Professor, Linzagolix, Uterus, Treatment, CET, EMA, NDA, Nasdaq, Uterine fibroid, FDA, BMD, Congress, Drug development, NASDAQ, Pharmaceutical industry, Communications satellite, Birth control

During SEUD, ObsEva will host a live symposium entitled, The potential of the oral GnRH antagonist: a personalized approach for women with uterine fibroids, chaired by Professor Charles Chapron on Friday, December 10, 2021, at 1:00 p.m. CET.

Key Points: 
  • During SEUD, ObsEva will host a live symposium entitled, The potential of the oral GnRH antagonist: a personalized approach for women with uterine fibroids, chaired by Professor Charles Chapron on Friday, December 10, 2021, at 1:00 p.m. CET.
  • With deep expertise in clinical development, Obseva is passionate about the pursuit of advances that benefit women and their health and the importance of delivering truly meaningful innovation in this space.
  • Through strategic in-licensing and disciplined drug development, Obseva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroids, endometriosis, and preterm labor.
  • These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements.

Women's Health research Collaborative Partners with Pharmacosmos and Blood Management Leader to Advance Identification of Women with Heavy Menstrual Bleeding and Iron Deficiency

Retrieved on: 
Tuesday, November 23, 2021
Patient, Senior, Menstruation, Industry, NIH, Partnership, Woman, MD, Health, Prevalence, HMB, Doctor of Philosophy, ID, Ageing, Gaps, Medical college, Female, View, Research, World Blood Donor Day, Risk, Transfusion medicine, Transplant, Iron deficiency, Therapy, Multimedia, Medical College of Wisconsin, Growth, Medical device, Pharmaceutical industry, Birth control

NEW YORK, Nov. 23, 2021 /PRNewswire/ -- The Women's Health Research Collaborative (WHrC) announces a collaborative partnership amongst multiple stakeholders to address the related issues of iron deficiency (ID) and heavy menstrual bleeding (HMB) through patient-centered research.

Key Points: 
  • NEW YORK, Nov. 23, 2021 /PRNewswire/ -- The Women's Health Research Collaborative (WHrC) announces a collaborative partnership amongst multiple stakeholders to address the related issues of iron deficiency (ID) and heavy menstrual bleeding (HMB) through patient-centered research.
  • The study runs through December 2022, with analysis in 2023 and is being funded by an unrestricted grant from Pharmacosmos Therapeutics.
  • "This work should help us understand more about the prevalence of iron deficiency in reproductive aged women, particularly in relationship with their self described menstrual experience" said Dr. Munro.
  • "Reproductive-aged women who donate blood are at high risk for iron deficiency.

Kioxia Delivers PCIe® 4.0 Performance to Everyday PC Users

Retrieved on: 
Tuesday, November 16, 2021
Technology, Hardware, Semiconductor, Consumer Electronics, S, NVM Express, Industry, NAND, Gen4 Energy, Opal, BICS, PCI Express, GT, Technology, TB, HMB, Multimedia, Software, Revolution, Sale, PCI-SIG, Personal computer, NVM, Toshiba, Solid-state drive, Kioxia, Corporation, VML, SSD, Name, Memory, Microsoft, Video game console, Computer data storage

Kioxia Corporation , a world leader in memory solutions, today announced that it has bolstered its lineup of PCIe 4.0 solid state drives (SSDs) with the addition of the KIOXIA BG5 Series.

Key Points: 
  • Kioxia Corporation , a world leader in memory solutions, today announced that it has bolstered its lineup of PCIe 4.0 solid state drives (SSDs) with the addition of the KIOXIA BG5 Series.
  • Designed to bring a suitable balance of performance, cost and power to everyday gamers and PC users, the KIOXIA BG5 Series is built with a PCIe 64 GT/s interface (Gen4 x4 lanes) and accelerated by Kioxias fifth-generation BiCS FLASH 3D flash memory technology.
  • KIOXIA BG5 SSDs also support the latest matured Host Memory Buffer (HMB) technology to realize a finely optimized DRAM-less SSD.
  • The KIOXIA BG5 ships in a compact M.2 2230 single-sided, thermally optimized form factor enabling mobility and work-from-home lifestyles.

KIOXIA Delivers PCIe 4.0 Performance to Everyday PC Users

Retrieved on: 
Monday, November 15, 2021
Technology, Semiconductor, Security, Satellite, Other Technology, Telecommunications, Nanotechnology, Software, Audio, Video, VoIP, Networks, Internet, Mobile, Wireless, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, S, NVM Express, Industry, Gen4 Energy, Opal, BICS, PCI Express, GT, 3D, Technology, TB, HMB, Multimedia, Software, Revolution, Â, PCI-SIG, Personal computer, NVM, MB, Solid-state drive, VML, SSD, Marketing, Name, Computer data storage

Designed to bring a suitable balance of performance, cost and power to everyday gamers and PC users, the KIOXIA BG5 Series is built with a PCIe 64 GT/s interface (Gen4 x4 lanes) and accelerated by the companys fifth-generation BiCS FLASH 3D flash memory technology.

Key Points: 
  • Designed to bring a suitable balance of performance, cost and power to everyday gamers and PC users, the KIOXIA BG5 Series is built with a PCIe 64 GT/s interface (Gen4 x4 lanes) and accelerated by the companys fifth-generation BiCS FLASH 3D flash memory technology.
  • View the full release here: https://www.businesswire.com/news/home/20211115005084/en/
    KIOXIA BG5 Series drives deliver a suitable balance of performance, cost and power to everyday gamers and PC users.
  • The fact that KIOXIA realized PCIe 4.0 performance with a DRAM-less architecture is a win for mainstream client applications.
  • With this latest addition to our comprehensive PCIe 4.0 SSD portfolio, KIOXIA is delivering premium performance to the mainstream swim-lane by enabling PCIe 4.0 without sacrificing affordability, said Ichhaporia.

Nirvana Water Sciences wins Best Technology Innovation at Global Water Drinks Awards

Retrieved on: 
Monday, October 25, 2021
Science, Research, Quality of life, D3, HMB, Leadership, Technology, Golden Ticket Award for Best New Ride, Water, Dietary supplement

NEW YORK, Oct. 25, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is pleased to have won Best Technology Innovation for its Nirvana HMB spring water at the 2021 Global Water Drinks Awards.

Key Points: 
  • NEW YORK, Oct. 25, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is pleased to have won Best Technology Innovation for its Nirvana HMB spring water at the 2021 Global Water Drinks Awards.
  • In addition to its win for innovation, Nirvana was also a finalist in the categories of Best New Water Concept, Best Marketing/Social Media Campaign, and Best New Brand, all for its innovative and unique Nirvana HMB spring water.
  • Organized by the international food and drink experts Zenith Global, the 7th annual Global Water Drinks Awards attracted over 165 entries with participation from every continent worldwide.
  • In Q1 2022 it will introduce Nirvana HMB + D3, complementing its signature Nirvana HMB spring water and adding to Nirvana's growing product line of innovative HMB infused spring water products.

Nirvana Water Sciences will showcase its exclusive muscle wellness spring water at IHRSA

Retrieved on: 
Wednesday, October 13, 2021
Water, Inflammation, Muscle, HMB, Multimedia, Athlete, Coronavirus Scientific Advisory Board (Turkey), FACS, MD, Quality of life, Electrolyte, Science, Research, Dietary supplement

NEW YORK, Oct. 13, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is introducing its clinically proven muscle wellness spring water to the fitness community at the 40th annual IHRSA International Convention and Trade Show in Dallas Texas this week.

Key Points: 
  • NEW YORK, Oct. 13, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is introducing its clinically proven muscle wellness spring water to the fitness community at the 40th annual IHRSA International Convention and Trade Show in Dallas Texas this week.
  • Nirvana HMB spring water is infused with myHMB Clear, the patented water-soluble form of eta-hydroxy eta-methylbutyrate (HMB) which is licensed exclusively to Nirvana.
  • Now, for the first time ever, HMB is water soluble, and infused into pure spring water in Nirvana HMB.
  • In addition to its line of muscle wellness water, Nirvana is introducing an electrolyte infused spring water.